Pudendal Neuralgia

A distinct entrapment neuropathy within the broader chronic pelvic pain spectrum covered on Functional Anorectal Pain & Coccygodynia — split onto its own page given the depth of its diagnostic and (unusually procedural, for a "functional disorders" chapter) surgical treatment literature.

Anatomy and mechanism

The pudendal nerve arises from sacral roots S2–S4, carrying both motor and sensory fibers to the anogenital area and pelvic muscles. It passes between the sacrospinous and sacrotuberous ligaments near the ischial spine before entering Alcock's canal. The most common etiology — also called Alcock's canal syndrome — is entrapment at one or more of four possible levels: (1) between the piriformis muscle and the sacral hypogastric fascia (the infrapiriformis canal), (2) the interligamentary space between the sacrospinous and sacrotuberous ligaments, (3) Alcock's canal itself, and (4) the subpubic dorsal nerve canal.

Presentation and diagnosis

Knifelike pain or a foreign-body sensation in the anus, vagina, or perineum; usually worsens through the day and may be unilateral. The ischial spine may be tender to palpation, and defecation can trigger pain with a delay of several minutes to an hour. Diagnosis is often delayed years given its difficulty.

Nantes criteria (2006 multidisciplinary consensus, Nantes, France) — five required diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment:

1. Pain in the pudendal nerve's anatomical territory (anus to clitoris/penis).
2. Pain worsened by sitting (excess pressure on the nerve).
3. No nocturnal waking due to pain.
4. No objective sensory loss on exam (a superficial perineal sensory deficit instead suggests a sacral nerve root lesion, not pudendal entrapment).
5. Pain relieved by an anesthetic pudendal nerve block (not itself specific — only localizes pain to the pudendal nerve's territory).

Exclusion criteria: purely coccygeal, gluteal, or hypogastric pain outside the pudendal territory; exclusively paroxysmal pain; exclusively pruritic symptoms; or imaging findings that explain the symptoms independently.

Only operative confirmation of nerve entrapment plus postoperative pain relief can formally confirm the diagnosis, but MR neurography is an increasingly used, less invasive diagnostic/management adjunct.

Treatment ladder

Medical/interventional options are typically tried before surgical decompression is offered for nonsurgical treatment failures.

Pudendal nerve block

Performed in the OR via palpated landmarks (transvaginal or transanal approach), though CT-guided injection into the sacrospinous ligament and Alcock's canal is preferred. A 95-patient retrospective review of CT-guided dual-site injection (lidocaine, ropivacaine, cortivazol) found ≥50% pain reduction in 63% of patients at 1 month, 50% at 3 months, and 25% at 6 months, with no major complications — response durability clearly wanes over time. A randomized double-blind trial found adding corticosteroid to the local anesthetic block gave no statistically significant improvement in pain, function, or quality of life over local anesthetic alone.

Neuromodulation

Pudendal neuromodulation and conus medullaris stimulation have reported success (in addition to sacral neuromodulation). A 19-patient retrospective review of pudendal neuromodulation (quadripolar lead, 2-week test period before permanent implantation) found complete relief in 3, near-complete in 3, significant/remarkable improvement in 10, and slight relief in 3 — felt more effective than nerve block, and rated more effective than prior sacral neuromodulation by 3 of 4 patients who had tried both. A separate 27-patient study of conus medullaris stimulation (following failed pudendal decompression surgery) found 100% of implanted patients remained long-term responders, with sitting time tripling and ~55.5% mean estimated improvement sustained over a mean 15-month follow-up.

Nerve ablation

CT-guided cryoablation was durably effective at 6 months in 9/11 patients (82%) with no procedure- related complications in one study. Transgluteal pulsed radiofrequency ablation has case-report-level support.

Fat grafting

Mechanism unclear (possible anti-inflammatory effect of adipose-derived stem cells, mechanical cushioning). A 15-patient case series of pudendal nerve lipofilling into Alcock's canal found 10 pain-free at 12 months.

Operative decompression

Recommended after failure of medical treatment; ideally addresses all four possible entrapment levels (see "Anatomy and mechanism" above) in a single operation. Response to nerve infiltration predicts surgical success — surgery is not recommended when nerve infiltration fails to help. A 32-patient RCT found pudendal nerve decompression/transposition superior to nonsurgical treatment at 3 and 6 months; among patients with successful decompression at 1 year, 8/10 remained successful at 4 years, supporting durable long-term benefit.

Multiple surgical approaches exist — transgluteal, transperineal, transischiorectal fossa, and laparoscopic — with newer hybrid endoscopic-assisted techniques aiming to improve visualization and safety:

• Laparoscopic decompression with omental flap protection ("Istanbul technique") — complete division of the sacrospinous ligament, splitting of the inner levator ani, with an omental flap wrapping the decompressed nerve; 27 patients, 80% with >80% pain-score reduction at 6 months, quality-of-life gains sustained to 12 months.
• "Operative pudendoscopy" — endoscope-assisted transperineal decompression (historically a blind procedure) allowing direct visualization of each decompression step and controlled division of the sacrospinous ligament; 113 patients, 73% improved, 42% with ≥50% pain reduction. A learning curve of ~60 cases was noted, with larger pain reductions achieved by the more experienced surgeon.
• Repeat decompression for surgical failure — technically challenging but effective in the majority, per one series using transgluteal approach with intraoperative nerve monitoring, microscope-assisted adhesiolysis from the piriformis to distal Alcock's canal, NeuraWrap nerve protector plus platelet-rich plasma, a continuous local-anesthetic catheter, and cadaveric-ligament reconstruction of the sacrotuberous ligament; 8/9 patients improved (2 with complete resolution) at a mean 23-month follow-up, with no reported symptom worsening.

Related pages

• Functional Anorectal Pain & Coccygodynia — proctalgia fugax is specifically linked to pudendal entrapment in a subset of patients (68-patient cohort, pudendal block relief in 90% combined).
• Irritable Bowel Syndrome (IBS) and the chronic pelvic pain overview on Functional Anorectal Pain & Coccygodynia — the broader pelvic pain context this entity sits within.

Open items / gaps

• All content is textbook-level/secondary, itself built almost entirely from small case series/ retrospective cohorts and a small number of RCTs (the decompression-vs-nonsurgical RCT is n=32; the corticosteroid-block RCT and the CT-guided-injection review are the largest studies cited). None of the several named operative techniques have been compared head-to-head.
• No RCT directly compares neuromodulation vs. operative decompression as first invasive-tier treatment — sequencing (block → neuromodulation/ablation → decompression) is expert-consensus practice pattern rather than trial-validated.